Insider trading

Period: 120 months Stock: ONC + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

455 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

455 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

455 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

455 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
455 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
455 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

455 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
15 Sep 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated
$5.58M 190,203 at 29.31
9.9%
14 Sep 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated 9×
$13.90M 37,877 at 367.02
100%
Sold half or more
14 Sep 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated
$4.45M 157,600 at 28.22
6.5%
13 Sep 2021
Huang Jane CMO, Hematology
Sold, plan not stated 8×
$4.62M 12,901 at 358.14
100%
Sold half or more
10 Sep 2021
AMGEN INC 10% owner
Bought
$50.00M 165,529 at 302.06
0.9%
First buy on file
2 Sep 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated 9×
$8.04M 24,499 at 328.21
100%
Sold half or more
2 Sep 2021
Huang Jane CMO, Hematology
Sold, plan not stated
$178.31K 545 at 327.18
100%
Sold half or more
1 Sep 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated 4×
$8.31M 25,501 at 325.73
100%
Sold half or more
1 Sep 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated 2×
$3.11M 127,558 at 24.34
4.2%
1 Sep 2021
Huang Jane CMO, Hematology
Sold, plan not stated
$168.31K 542 at 310.53
100%
Sold half or more
31 Aug 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated 9×
$10.42M 34,281 at 303.82
100%
Sold half or more
31 Aug 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated
$1.82M 76,800 at 23.67
2.0%
5 Aug 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated 14×
$3.50M 10,362 at 337.55
100%
Sold half or more
5 Aug 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated
$880.30K 34,100 at 25.82
0.8%
4 Aug 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated 8×
$10.93M 31,747 at 344.13
100%
Sold half or more
4 Aug 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated
$1.28M 49,100 at 26.08
1.1%
3 Aug 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated 18×
$14.16M 41,959 at 337.48
100%
Sold half or more
3 Aug 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated
$1.04M 41,400 at 25.17
0.8%
22 Jul 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated 12×
$3.60M 11,316 at 317.98
100%
Sold half or more
22 Jul 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated
$1.37M 57,900 at 23.71
1.1%
21 Jul 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated 9×
$4.71M 15,260 at 308.48
100%
Sold half or more
21 Jul 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated
$292.47K 11,900 at 24.58
0.2%
20 Jul 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated 6×
$5.10M 15,995 at 318.69
100%
Sold half or more
20 Jul 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated
$681.64K 27,700 at 24.61
0.5%
15 Jul 2021
Huang Jane CMO, Hematology
Sold, plan not stated 6×
$6.98M 21,000 at 332.42
100%
Sold half or more
8 Jul 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated 14×
$5.06M 15,881 at 318.49
100%
Sold half or more
8 Jul 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated
$1.24M 51,300 at 24.24
0.8%
7 Jul 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated 15×
$8.21M 26,046 at 315.34
100%
Sold half or more
7 Jul 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated
$1.02M 40,700 at 25.14
0.6%
6 Jul 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated 9×
$4.25M 13,075 at 325.01
100%
Sold half or more
6 Jul 2021
Wu Xiaobin President, COO & GM China
Sold, plan not stated 8×
$3.31M 10,180 at 325.53
100%
Sold half or more
6 Jul 2021
OYLER JOHN Chief Executive Officer
Sold, plan not stated
$1.13M 44,300 at 25.42
0.7%
1 Jul 2021
Wang Xiaodong Director
Sold, plan not stated 6×
$1.69M 4,848 at 348.15
100%
Sold half or more
1 Jul 2021
Wang Julia Aijun Chief Financial Officer
Sold, plan not stated
$107.51K 308 at 349.06
100%
Sold half or more
29 Jun 2021
Huang Jane CMO, Hematology
Sold, plan not stated 6×
$528.20K 1,500 at 352.13
100%
Sold half or more
28 Jun 2021
Wang Lai Global Head of R&D
Sold, plan not stated
$164.93K 455 at 362.48
100%
Sold half or more
28 Jun 2021
Liang Howard CFO & Chief Strategy Officer
Sold, plan not stated
$162.79K 446 at 365.00
100%
Sold half or more
28 Jun 2021
Huang Jane CMO, Hematology
Sold, plan not stated
$155.13K 425 at 365.00
100%
Sold half or more
18 Jun 2021
Wu Xiaobin President, COO & GM China
Sold, plan not stated
$382.55K 1,156 at 330.93
100%
Sold half or more
18 Jun 2021
Wang Lai Global Head of R&D
Sold, plan not stated
$265.58K 802 at 331.15
100%
Sold half or more
18 Jun 2021
Liang Howard CFO & Chief Strategy Officer
Sold, plan not stated
$158.38K 486 at 325.89
100%
Sold half or more
18 Jun 2021
Huang Jane CMO, Hematology
Sold, plan not stated
$152.73K 469 at 325.66
100%
Sold half or more
10 Jun 2021
Sold, plan not stated 4×
$998.35K 2,836 at 352.03
100%
Sold half or more
9 Jun 2021
Sold, plan not stated 3×
$1.11M 3,164 at 351.35
100%
Sold half or more
7 Jun 2021
Wu Xiaobin President, COO & GM China
Sold, plan not stated 3×
$1.20M 3,398 at 352.54
100%
Sold half or more
7 Jun 2021
Wang Lai Global Head of R&D
Sold, plan not stated
$232.39K 656 at 354.26
100%
Sold half or more
7 Jun 2021
Liang Howard CFO & Chief Strategy Officer
Sold, plan not stated
$230.20K 650 at 354.16
100%
Sold half or more
7 Jun 2021
Huang Jane CMO, Hematology
Sold, plan not stated
$211.99K 603 at 351.55
100%
Sold half or more
1 Jun 2021
Huang Jane CMO, Hematology
Sold, plan not stated
$195.83K 540 at 362.64
100%
Sold half or more
28 May 2021
Huang Jane CMO, Hematology
Sold, plan not stated 6×
$534.45K 1,500 at 356.30
100%
Sold half or more
Showing 201–250 of 455. ← Newer Page 5 of 10 Older →